National Medical Commission gets WFME recognition; Indian medical graduates can now practise abroad

-

According to a press statement from the Union Health Ministry, India’s National Medical Commission (NMC) has been granted the coveted World Federation for Medical Education (WFME) Recognition Status for a period of ten years.

According to the statement, WFME accreditation will allow Indian medical graduates to continue postgraduate studies and practise in other nations that need WFME recognition, such as the United States, Canada, Australia, and New Zealand.

Under this accreditation, all 706 current medical colleges become WFME accredited, and any new medical colleges established in the next ten years become WFME accredited immediately.

Because of our globally recognised standards, this would also make India an appealing location for overseas students.

In addition, the NMC would have the opportunity to improve the quality and standards of medical education in India by aligning them with worldwide best practises and benchmarks.

According to the release, the recognition will boost the international recognition and reputation of Indian medical schools and professionals, facilitate academic collaborations and exchanges, promote continuous improvement and innovation in medical education, and foster a quality assurance culture among medical educators and institutions.

The World Federation for Medical Education (WFME) is a global organization dedicated to enhancing the quality of medical education worldwide. WFME’s mission is to strive for better health care for all mankind; WFME’s primary objective is to enhance the quality of medical education worldwide, with the promotion of the highest scientific and ethical standards in medical education, according to the Health Ministry press release.

The release stated that the Education Commission on Foreign Medical Education (ECFMG) is the primary body in the United States that oversees the policies and regulations around licensing International Medical Graduates (IMGs).

In order to take the USMLEs, and to apply for residency all IMGs must be certified by ECFMG. The Education Commission on Foreign Medical Education (ECFMG) is the primary body in the United States that oversees the policies and regulations around licensing International Medical Graduates (IMGs).

In order to take the USMLEs, and to apply for residency all IMGs must be certified by ECFMG. This certification typically takes place after the completion of the 2nd year of a medical program, and before taking the USMLE Step 1 examination. In 2010, the ECFMG announced a new requirement that will become effective in the year 2024 (was set for 2023 but was moved to 2024 due to COVID).

The new rule states that “starting in 2024, individuals applying for ECFMG Certification must be a student or graduate of a medical school that is appropriately accredited. More specifically, the school must be accredited by an accrediting agency that is officially recognized by the World Federation for Medical Education (WFME).”

The WFME recognition process entails a fee of ₹ 4,98,5142 ($60,000) per medical college, which covers the expenses of the site visit team and their travel and accommodation.

This means that the total cost for the 706 medical colleges in India to apply for WFME recognition would have been approximately ₹ 351.9 crore ($4,23,60,000).

It is noteworthy that NMC has taken recognition of WFME which shall be applicable to all medical colleges under its umbrella.



from Firstpost India Latest News https://ift.tt/5tKADbs
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more